TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -50.74%-1.72M | ---- | 62.43%-1.14M | ---- | 50.04%-3.04M | ---- | -186.00%-6.09M | ---- | -190.94%-2.13M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 50.00%-9K | ---- | 14.29%-18K | ---- | 58.00%-21K | ---- | 43.82%-50K | ---- | -394.44%-89K |
Impairment and provisions: | ---- | 446.00%865K | ---- | -156.82%-250K | ---- | -80.26%440K | ---- | 279.08%2.23M | ---- | --588K |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --282K | ---- | ---- |
-Impairmen of inventory (reversal) | ---- | --414K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | -23.81%96K | ---- | --126K | ---- | ---- | ---- | 7,900.00%400K | ---- | --5K |
-Impairment of goodwill | ---- | --355K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | -185.45%-376K | ---- | -71.56%440K | ---- | 165.35%1.55M | ---- | --583K |
Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --46K |
-Fair value of investment properties (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --46K |
Asset sale loss (gain): | ---- | ---- | ---- | 60.91%-43K | ---- | -124.49%-110K | ---- | -110.19%-49K | ---- | 2,431.58%481K |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | 60.91%-43K | ---- | -27.91%-110K | ---- | -117.88%-86K | ---- | 2,431.58%481K |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --37K | ---- | ---- |
Depreciation and amortization: | ---- | -16.30%611K | ---- | -13.92%730K | ---- | -47.78%848K | ---- | 40.85%1.62M | ---- | 69.31%1.15M |
-Amortization of intangible assets | ---- | -3.17%549K | ---- | 0.00%567K | ---- | -24.10%567K | ---- | 84.90%747K | ---- | --404K |
Financial expense | ---- | -75.00%1K | ---- | 100.00%4K | ---- | --2K | ---- | ---- | ---- | ---- |
Special items | ---- | ---- | ---- | -55.68%312K | ---- | 648.94%704K | ---- | 623.08%94K | ---- | -93.16%13K |
Operating profit before the change of operating capital | ---- | 37.50%-255K | ---- | 65.39%-408K | ---- | 47.39%-1.18M | ---- | -3,657.14%-2.24M | ---- | -98.04%63K |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -1,879.17%-854K | ---- | 175.00%48K | ---- | -6,300.00%-64K | ---- | -102.50%-1K | ---- | 221.21%40K |
Accounts receivable (increase)decrease | ---- | -80.47%503K | ---- | 223.55%2.58M | ---- | -228.78%-2.09M | ---- | 3,665.12%1.62M | ---- | 122.63%43K |
Accounts payable increase (decrease) | ---- | 86.96%-660K | ---- | -218.72%-5.06M | ---- | 35,425.00%4.26M | ---- | -99.01%12K | ---- | 572.27%1.21M |
Cash from business operations | -888.77%-3.7M | 55.50%-1.27M | 86.42%-374K | -404.28%-2.85M | -1,673.71%-2.75M | 253.03%935K | 114.51%175K | -145.09%-611K | -203.78%-1.21M | -50.44%1.36M |
Other taxs | ---- | 86.67%-6K | ---- | -850.00%-45K | ---49K | --6K | ---- | ---- | ---- | -3.06%-572K |
Net cash from operations | -888.77%-3.7M | 55.99%-1.27M | 86.66%-374K | -407.12%-2.89M | -1,701.71%-2.8M | 254.01%941K | 114.51%175K | -178.03%-611K | -69.86%-1.21M | -64.07%783K |
Cash flow from investment activities | ||||||||||
Interest received - investment | -74.36%10K | -50.00%9K | 254.55%39K | -14.29%18K | 83.33%11K | -58.00%21K | 50.00%6K | -43.82%50K | -33.33%4K | 394.44%89K |
Purchase of fixed assets | 95.89%-25K | -100.00%-4K | -30,300.00%-608K | 81.82%-2K | ---2K | -83.33%-11K | ---- | 99.53%-6K | 99.75%-3K | -85.05%-1.28M |
Purchase of intangible assets | ---806K | ---173K | ---- | ---- | 78.57%-9K | 95.57%-66K | 38.24%-42K | 18.37%-1.49M | 48.09%-68K | -329.18%-1.82M |
Sale of subsidiaries | --858K | ---- | ---- | 1,003.92%1.13M | --1.13M | 148.34%102K | ---- | 71.06%-211K | ---- | -579.61%-729K |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---836K | ---836K | ---- | ---- | ---- |
Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.12M | ---- | ---- |
Net cash from investment operations | 106.50%37K | -114.71%-168K | -150.53%-569K | 244.56%1.14M | 229.13%1.13M | -47.11%-790K | -1,201.49%-872K | 85.64%-537K | 95.00%-67K | 2.96%-3.74M |
Net cash before financing | -288.23%-3.66M | 17.62%-1.44M | 43.77%-943K | -1,257.62%-1.75M | -140.60%-1.68M | 113.15%151K | 45.25%-697K | 61.16%-1.15M | 37.87%-1.27M | -76.58%-2.96M |
Cash flow from financing activities | ||||||||||
Issuing shares | ---- | --440K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.34M |
Interest paid - financing | 87.50%-1K | 75.00%-1K | -300.00%-8K | -100.00%-4K | ---2K | ---2K | ---- | ---- | ---- | ---- |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --155K | --155K | ---- |
Net cash from financing operations | 92.45%-20K | 582.28%381K | -579.49%-265K | -243.48%-79K | ---39K | -114.84%-23K | ---- | -88.46%155K | --155K | --1.34M |
Effect of rate | 49.67%-377K | 61.54%-15K | -704.03%-749K | 9.30%-39K | 402.44%124K | -514.29%-43K | -115.79%-41K | 50.00%-7K | -111.11%-19K | ---14K |
Net Cash | -204.72%-3.68M | 42.04%-1.06M | 29.60%-1.21M | -1,527.34%-1.83M | -146.20%-1.72M | 112.89%128K | 37.66%-697K | 38.44%-993K | 45.44%-1.12M | 3.64%-1.61M |
Begining period cash | -33.84%17.6M | -35.37%3.41M | 404.11%26.6M | 1.64%5.28M | 1.64%5.28M | -16.15%5.19M | -16.15%5.19M | -20.81%6.19M | -20.81%6.19M | -17.64%7.82M |
Items Period | ---- | ---80K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash at the end | -45.05%13.54M | -33.84%2.26M | 568.84%24.64M | -35.37%3.41M | -17.27%3.68M | 1.64%5.28M | -11.89%4.45M | -16.15%5.19M | -12.26%5.05M | -20.81%6.19M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | USD | HKD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited | -- | CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.